- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT00670644
Self-Care for Lymphedema in Patients With Breast Cancer
Breast Cancer Treatment Related Lymphedema Self Care Practices
RATIONALE: Identifying why patients don't do self care for lymphedema may help doctors plan better at-home self-care treatment.
PURPOSE: This research study is looking at self-care practices for lymphedema in patients with breast cancer.
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
OBJECTIVES:
Primary
- To systematically identify and describe the barriers to completing recommended at home self-care of lymphedema in patients with breast cancer.
- To identify patient recalled instructions as to at home self-care practices for lymphedema as told to them by healthcare professionals and others.
- To identify the current at home self-care practices of breast cancer survivors with treatment treated lymphedema.
Secondary
- To examine the relationship between at home self-care activities and symptoms in breast cancer survivors with lymphedema.
- To examine the relationship between at home self-care activities and quality of life in breast cancer survivors with lymphedema.
- To identify patient-perceived benefits to at home self-care.
OUTLINE: Patients complete questionnaires about their breast cancer diagnosis and treatment history, lymphedema history and problems, and years of education and income. Patients also complete surveys about home self-care practices for lymphedema and any benefits, burdens, or barriers of at home care.
Studietype
Registrering (Faktiske)
Kontakter og plasseringer
Studiesteder
-
-
Tennessee
-
Nashville, Tennessee, Forente stater, 37232-6838
- Vanderbilt-Ingram Cancer Center
-
Nashville, Tennessee, Forente stater, 37064
- Vanderbilt-Ingram Cancer Center - Cool Springs
-
Nashville, Tennessee, Forente stater, 37064
- Vanderbilt-Ingram Cancer Center at Franklin
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Prøvetakingsmetode
Studiepopulasjon
Beskrivelse
DISEASE CHARACTERISTICS:
- History of breast cancer
- Lymphedema in one or both arms that occurred during or after breast cancer treatment
Must have received prior lymphedema treatment by a healthcare professional
- Patients with self-reported arm swelling subsequent to breast cancer treatment that has not been treated by a healthcare professional are not eligible
- Hormone receptor status not specified
PATIENT CHARACTERISTICS:
- Menopausal status not specified
- English speaking
PRIOR CONCURRENT THERAPY:
- See Disease Characteristics
Studieplan
Hvordan er studiet utformet?
Designdetaljer
Hva måler studien?
Primære resultatmål
Resultatmål |
Tidsramme |
---|---|
Identification and description of barriers to completing recommended at home self-care of lymphedema
Tidsramme: one time only for approximately 15 minutes
|
one time only for approximately 15 minutes
|
Identification of patients recalled instructions as to at home self-care practices for lymphedema as told to them by healthcare professionals and others
Tidsramme: one time only for approximately 15 minutes
|
one time only for approximately 15 minutes
|
Identification of current at home self-care practices for lymphedema
Tidsramme: one time only for approximately 15 minutes
|
one time only for approximately 15 minutes
|
Sekundære resultatmål
Resultatmål |
Tidsramme |
---|---|
Relationship between at home self-care activities, symptoms, and quality of life in breast cancer survivors with lymphedema
Tidsramme: one time only for approximately 15 minutes
|
one time only for approximately 15 minutes
|
Identification of patient-perceived benefits to at home self-care
Tidsramme: one time only for approximately 15 minutes
|
one time only for approximately 15 minutes
|
Samarbeidspartnere og etterforskere
Sponsor
Samarbeidspartnere
Etterforskere
- Studiestol: Shiela H. Ridner, MSN, PhD, RN, Vanderbilt-Ingram Cancer Center
Studierekorddatoer
Studer hoveddatoer
Studiestart
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- CDR0000587714
- P30CA068485 (U.S. NIH-stipend/kontrakt)
- VU-VICC-SUPP-0628
- VU-VICC-060480
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Brystkreft
-
Tianjin Medical University Cancer Institute and...Guangxi Medical University; Sun Yat-sen University; Chinese PLA General Hospital og andre samarbeidspartnereFullførtThe Clinical Application Guide of Conebeam Breast CTKina
-
Novartis PharmaceuticalsFullførtMetastatisk brystkreft (MBC) | Locally Advance Breast Cancer (LABC)Storbritannia, Spania
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.UkjentHR-positiv, HER2-negativ og PIK3CA Mutation Advanced Breast CancerKina
-
Emory UniversityNational Cancer Institute (NCI)TilbaketrukketPrognostisk stadium IV brystkreft AJCC v8 | Metastatisk malign neoplasma i hjernen | Metastatisk brystkarsinom | Anatomic Stage IV Breast Cancer American Joint Committee on Cancer (AJCC) v8
-
NRG OncologyNational Cancer Institute (NCI)Aktiv, ikke rekrutterendeAnatomisk stadium IV brystkreft AJCC v8 | Prognostisk stadium IV brystkreft AJCC v8 | Metastatisk malign neoplasma i beinet | Metastatisk malign neoplasma i lymfeknutene | Metastatisk malign neoplasma i leveren | Metastatisk brystkarsinom | Metastatisk malign neoplasma i lungen | Metastatisk malign neoplasma... og andre forholdForente stater, Canada, Saudi-Arabia, Korea, Republikken
Kliniske studier på questionnaire administration
-
Cairn DiagnosticsFullført
-
PATHMinistry of Health, Zambia; AKROS Global HealthFullført
-
Analgesic SolutionsGrünenthal GmbHFullførtSmertefull diabetisk nevropati (PDN)Forente stater
-
Wayne State UniversityUkjentOpioidavhengighet | Opioidbruk | BenbruddForente stater
-
Gerd MikusFullført
-
University of California, San FranciscoNational Institute of Allergy and Infectious Diseases (NIAID); Stanford... og andre samarbeidspartnereHar ikke rekruttert ennå
-
Pyae Linn AungUniversity of South Florida; Mahidol UniversityAktiv, ikke rekrutterendeMalaria | Plasmodium Vivax | Myanmar | Mass Drug Administration | PrimaquineMyanmar
-
University of Alabama at BirminghamTilbaketrukketRespirasjonsdepresjon
-
Nanfang Hospital of Southern Medical UniversityHar ikke rekruttert ennåKjemoterapi-indusert perifer nevropati | AcetylkarnitinKina
-
Universitas Negeri SemarangMinistry of Research, Technology and Higher Education, Republic of IndonesiaUkjentOksidativt stress | Anstrengelse; OverskuddIndonesia